Geulah Livshits
Stock Analyst at Chardan Capital
(2.12)
# 2,802
Out of 4,877 analysts
201
Total ratings
34%
Success rate
-3.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $82 | $48.64 | +68.59% | 14 | Jun 26, 2025 | |
| PASG Passage Bio | Maintains: Buy | $6 | $0.40 | +1,398.88% | 5 | Jun 24, 2025 | |
| IMRX Immuneering | Maintains: Buy | $13 | $3.37 | +285.76% | 12 | Jun 18, 2025 | |
| SNTI Senti Biosciences | Maintains: Buy | $12 | $2.12 | +466.04% | 9 | Jun 12, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 → $9 | $2.31 | +289.61% | 13 | May 29, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $46 → $17 | $2.45 | +593.88% | 18 | May 28, 2025 | |
| PRME Prime Medicine | Maintains: Buy | $16 → $12 | $2.47 | +385.83% | 5 | May 19, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $16 → $15 | $4.89 | +207.06% | 7 | May 19, 2025 | |
| IPSC Century Therapeutics | Maintains: Buy | $7 → $6 | $0.56 | +973.92% | 6 | May 16, 2025 | |
| MGX Metagenomi | Maintains: Buy | $13 → $12 | $1.47 | +716.33% | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $20 | $4.02 | +397.51% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $3.73 | +571.14% | 9 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $1.72 | +1,353.49% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 | $9.38 | +624.95% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $0.61 | +1,372.51% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 | $137.46 | +59.32% | 10 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $22.54 | +121.83% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.13 | - | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.20 | - | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $6.51 | +529.80% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $5.38 | +365.12% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.52 | +689.47% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $27.59 | +653.90% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.35 | +1,085.19% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $8.22 | +994.89% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $3.11 | +28.62% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $2.15 | +1,295.35% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.30 | +93.55% | 1 | Oct 27, 2020 |
CRISPR Therapeutics AG
Jun 26, 2025
Maintains: Buy
Price Target: $82
Current: $48.64
Upside: +68.59%
Passage Bio
Jun 24, 2025
Maintains: Buy
Price Target: $6
Current: $0.40
Upside: +1,398.88%
Immuneering
Jun 18, 2025
Maintains: Buy
Price Target: $13
Current: $3.37
Upside: +285.76%
Senti Biosciences
Jun 12, 2025
Maintains: Buy
Price Target: $12
Current: $2.12
Upside: +466.04%
Taysha Gene Therapies
May 29, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.31
Upside: +289.61%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $46 → $17
Current: $2.45
Upside: +593.88%
Prime Medicine
May 19, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.47
Upside: +385.83%
Solid Biosciences
May 19, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $4.89
Upside: +207.06%
Century Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.56
Upside: +973.92%
Metagenomi
May 15, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $1.47
Upside: +716.33%
May 13, 2025
Maintains: Buy
Price Target: $22 → $20
Current: $4.02
Upside: +397.51%
May 9, 2025
Maintains: Buy
Price Target: $28 → $25
Current: $3.73
Upside: +571.14%
May 9, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $1.72
Upside: +1,353.49%
May 9, 2025
Maintains: Buy
Price Target: $68
Current: $9.38
Upside: +624.95%
May 9, 2025
Maintains: Buy
Price Target: $9
Current: $0.61
Upside: +1,372.51%
May 7, 2025
Maintains: Buy
Price Target: $219
Current: $137.46
Upside: +59.32%
Apr 9, 2025
Initiates: Buy
Price Target: $50
Current: $22.54
Upside: +121.83%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.13
Upside: -
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.20
Upside: -
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $6.51
Upside: +529.80%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $5.38
Upside: +365.12%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $1.52
Upside: +689.47%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $27.59
Upside: +653.90%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $1.35
Upside: +1,085.19%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $8.22
Upside: +994.89%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $3.11
Upside: +28.62%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $2.15
Upside: +1,295.35%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $9.30
Upside: +93.55%